1 domain / 2 areas / 1 specialization
BTIG
Data updated
BTIG is a global financial services firm that provides institutional sales and trading, research, and investment banking services. Its website describes the firm as serving institutional and corporate clients across public markets, with a strong healthcare banking presence. The firm’s New York office at 65 East 55th Street is the address most prominently listed on BTIG’s site.
In the psychedelic ecosystem, BTIG is relevant primarily as a healthcare and capital markets intermediary rather than a dedicated psychedelic investor. BTIG’s healthcare investment banking coverage includes biotechnology and pharmaceuticals, which can overlap with psychedelic drug-development companies if they seek public-market financing, strategic advice, or aftermarket support.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
BTIG appears to be a public-markets-focused broker-dealer and investment bank with broad healthcare coverage rather than a specialist psychedelic fund. Its investment banking platform supports both public and private healthcare companies across biotechnology and pharmaceuticals, so its relevance to psychedelics is likely opportunistic and transaction-driven rather than thesis-led. Public materials support a global operating footprint and a New York base, but no public psychedelic-specific mandate was found.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 2002
- HQ
- New York, NY 10022 (65 East 55th Street), United States
- Website
- Visit